In memory
Valerie Harper's Resilience and What Lung Cancer Really Is
The beloved 'Rhoda' star lived openly with lung cancer for years. Here's what lung cancer really is — and why every story is different.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
On screen
Valerie Harper won hearts as Rhoda Morgenstern on The Mary Tyler Moore Show and its spin-off, Rhoda. She was diagnosed with lung cancer in 2009, and years later the disease spread. Harper spoke publicly and often about living with cancer, facing it with humor and determination and inspiring many people who were going through their own diagnoses. She died in 2019 at age 80. Her openness turned a difficult journey into a source of encouragement for others.
The reality
According to the National Cancer Institute, lung cancer includes two main types: non-small cell lung cancer and small cell lung cancer. It begins when cells in the lungs grow out of control. The NCI notes that smoking causes most lung cancers, but nonsmokers can also develop the disease. When cancer spreads beyond where it started to distant parts of the body, it is described as metastatic.
Harper's long, public experience of living with lung cancer helped many people see that a diagnosis is the start of a story, not the end of one.
What the story gets right — and what to remember
Harper's resilience was genuine and moving, but it is important to remember that her path was her own. Lung cancer varies enormously between individuals, and outcomes depend on many factors. That one person lived far longer than expected is inspiring, but it is not a prediction for anyone else. Her story is a reason to stay hopeful and informed and to lean on a healthcare team — not medical advice in itself.
Awareness, screening & prevention
The NCI notes that smoking causes most lung cancers, so avoiding or quitting tobacco is important for lung health, though lung cancer can also affect people who never smoked. The NCI provides information on lung cancer screening using low-dose CT scans, generally offered to people at higher risk. Because the right approach depends on the individual, whether screening makes sense is a conversation to have with a healthcare team. Paying attention to lasting or unusual symptoms and reporting them is always worthwhile.
Turning a story into something useful
Valerie Harper met a hard diagnosis with warmth and courage, and she let people watch her do it. Learning what lung cancer is, understanding that experiences differ widely, and talking openly with a healthcare team are all constructive responses. Free cancer education helps this kind of understanding reach more people, and supporting it keeps clear, hopeful information within everyone's reach.
Questions to ask a healthcare team
- Am I at higher risk for lung cancer, and would screening make sense for me?
- What does it mean when cancer is described as metastatic?
- What lung or breathing symptoms should I get checked?
- Where can I find reliable, plain-language information about lung cancer?